Treatment of Mood Disorders Secondary to Medical Conditions or Medications

Initial Assessment and Management

The American Society of Clinical Oncology recommends treating medical causes of depressive symptoms and delirium as the first step in management 1
The National Comprehensive Cancer Network suggests reviewing current medications and identifying those that may be contributing to mood symptoms, with consideration for dose adjustment or medication substitution when possible 1, 2
For mood disorders resulting from medication side effects, the American Academy of Child and Adolescent Psychiatry recommends considering dose reduction of the offending medication, switching to an alternative medication, or adding a medication to counteract specific side effects 3

The American Society of Clinical Oncology recommends using pharmacologic interventions delivered by appropriately trained individuals for optimal management of depressive symptoms or diagnosed mood disorder secondary to medical conditions 1
When selecting an antidepressant, the American Society of Clinical Oncology suggests considering adverse effect profiles, potential interactions with other medications, patient response to prior treatments, and patient preference 1
The American College of Physicians recommends using SSRIs as first-line agents for depression secondary to medical conditions due to their favorable side effect profile 5

The American Society of Clinical Oncology recommends psychotherapy, psychoeducational therapy, cognitive-behavioral therapy (CBT), and exercise as effective treatments for mood disorders secondary to medical conditions 1, 5
The American College of Physicians suggests that CBT has shown effectiveness equivalent to antidepressant medications and may be particularly useful when medication options are limited 5
The American Society of Clinical Oncology recommends offering support and providing education about depression and its management to all patients and their families 1

The National Comprehensive Cancer Network recommends psychotherapy with or without anxiolytics or antidepressants for cancer patients with mood disorders after eliminating medical causes 2
The American Academy of Child and Adolescent Psychiatry recommends careful assessment before initiating psychotropic medications in children and adolescents with mood disorders secondary to medical conditions or medications 3

The American Society of Clinical Oncology recommends implementing a stepped care model and tailoring interventions based on current symptom severity, level of functional impairment, presence or absence of risk factors, history of and response to previous treatments, patient preference, and persistence of symptoms after initial treatment 1

The American Society of Clinical Oncology recommends using standardized assessment tools such as the Patient Health Questionnaire-9 (PHQ-9), Hamilton Depression Rating Scale (HAM-D), or Hospital Anxiety and Depression Scale (HADS) to monitor treatment response 1
The American College of Physicians suggests continuing treatment for at least 4-9 months after satisfactory response for first episodes, with longer duration beneficial for recurrent episodes 4

The American Society of Clinical Oncology recommends avoiding failing to identify and address the underlying medical cause or medication side effect, mistaking behavioral and emotional reactions to psychosocial stressors as symptoms of an underlying biological illness, and using medications to address all of a patient's symptoms when psychosocial interventions may be more appropriate 1, 3